The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Effects of Graded Doses of Testosterone on Erythropoiesis in Healthy Young and Older Men
Open accessAbstract
CONTEXT: Erythrocytosis is a dose-limiting adverse effect of testosterone therapy, especially in older men. OBJECTIVE: Our objective was to compare the dose-related changes in hemoglobin and hematocrit in young and older men and determine whether age-related differences in erythropoietic response to testosterone can be explained by changes in erythropoietin and soluble transferrin receptor (sTfR) levels. DESIGN: We conducted a secondary analysis of data from a testosterone dose-response study in young and older men who received long-acting GnRH agonist monthly plus one of five weekly doses of testosterone enanthate (25, 50, 125, 300, or 600 mg im) for 20 wk. SETTING: The study took place at a General Clinical Research Center. PARTICIPANTS: Participants included 60 older men aged 60-75 yr and 61 young men aged 19-35 yr. OUTCOME MEASURES: Outcome measures included hematocrit and hemoglobin and serum erythropoietin and sTfR levels. RESULTS: Hemoglobin and hematocrit increased significantly in a linear, dose-dependent fashion in both young and older men in response to graded doses of testosterone (P<0.0001). The increases in hemoglobin and hematocrit were significantly greater in older than young men. There was no significant difference in percent change from baseline in erythropoietin or sTfR levels across groups in either young or older men. Changes in erythropoietin or sTfR levels were not significantly correlated with changes in total or free testosterone levels. CONCLUSIONS: Testosterone has a dose-dependent stimulatory effect on erythropoiesis in men that is more pronounced in older men. The testosterone-induced rise in hemoglobin and hematocrit and age-related differences in response to testosterone therapy may be mediated by factors other than erythropoietin and sTfR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Testosterone exerts erythrogenic effects that results in increases in both HCT and Hgb.23”
The cited source says what the claim attributes to it.
In the citing paper
“Circulating hemoglobin levels are androgen-dependent [82] and typically reported as 12% higher in males compared with females [4].”
From Transgender Women in the Female Category of Sport: Perspectives on Testosterone Suppression and Performance Advantage (2021) · cites this paper as [82]
In the citing paper
“In the Bhasin et al. (111) studies, in both young and older men the highest testosterone dose produced a 12% increase in blood hemoglobin compared with the lowest dose, reflecting a strong dose-response relationship (Fig. 6) (131).”
From Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance (2018) · cites this paper as [131]
In the citing paper
“Increased red blood cell mass (erythrocytosis) is the most common adverse event associated with testosterone therapy in clinical practice and in testosterone trials (2,3).”
From Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point (2014) · cites this paper as [3]
In the citing paper
“The meta-analyses of randomized testosterone trials have, however, reported very low frequency of neuro-occlusive events (2,3,20).”
From Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point (2014) · cites this paper as [3]
In the citing paper
“The effects of testosterone on red blood cell formation (hemoglobin and hematocrit) are dose dependent (14, 82, 83) while higher age is also a factor (44).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [83]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
Drüeke, T. B., Locatelli, F., Clyne, N., Eckardt, K., Macdougall, I. C., Tsakiris, D., Burger, H.-U., & Scherhag, A. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062276 · Cited by 2,094
Jones, M., Ibels, L. S., Schenkel, B., & Zagari, M. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00450.x · Cited by 1,812
Kalantar‐Zadeh, K. (2017) · American Journal of Nephrology · doi:10.1159/000455387 · Cited by 1,149
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R., Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., & Ross, C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3988 · Cited by 920
Calof, O. M., Singh, A. B., Lee, M. L., Kenny, A. M., Urban, R. J., Tenover, J. L., & Bhasin, S. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.11.1451 · Cited by 728
Page, S. T., Amory, J. K., Bowman, F. D., Anawalt, B. D., Matsumoto, A. M., Bremner, W. J., & Tenover, J. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1933 · Cited by 566
Cited by
Sorted by citations
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Self-citationTestosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00229 · Cited by 1,736
Pope, H. G., Wood, R. I., Rogol, A. D., Nyberg, F., Bowers, L. D., & Bhasin, S. (2013) · Endocrine Reviews · doi:10.1210/er.2013-1058 · Cited by 703
Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance
Handelsman, D. J., Hirschberg, A. L., & Bermon, S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00020 · Cited by 594
The sex difference in haemoglobin levels in adults—mechanisms, causes, and consequences
Murphy, W. G. (2014) · Blood Reviews · doi:10.1016/j.blre.2013.12.003 · Cited by 463
Caminiti, G., Volterrani, M., Iellamo, F., Marazzi, G., Massaro, R., Miceli, M., Mammi, C., Piepoli, M., Fini, M., & Rosano, G. M. C. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.078 · Cited by 444
Bachman, E., Travison, T. G., Basaria, S., Davda, M. N., Guo, W., Li, M., Connor Westfall, J., Bae, H., Gordeuk, V., & Bhasin, S. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt154 · Cited by 426
Wittert, G., Bracken, K., Robledo, K. P., Grossmann, M., Yeap, B. B., Handelsman, D. J., Stuckey, B., Conway, A., Inder, W., McLachlan, R., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30367-3 · Cited by 362
Long-Term Evaluation of Cross-Sex Hormone Treatment in Transsexual Persons
Wierckx, K., Mueller, S. C., Weyers, S., Caenegem, E. V., Roef, G. L., Heylens, G., & T'Sjoen, G. G. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02876.x · Cited by 338
Basaria, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61126-5 · Cited by 328
Low Free Testosterone Predicts Frailty in Older Men: The Health in Men Study
Hyde, Z., Flicker, L., Almeida, O. P., Hankey, G. J., McCaul, K. A., Chubb, S. A. P., & Yeap, B. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2754 · Cited by 286
Paediatric and adult-onset male hypogonadism
Salonia, A., Rastrelli, G., Hackett, G., Seminara, S. B., Huhtaniemi, I. T., Rey, R. A., Hellstrom, W. J. G., Palmert, M. R., Corona, G., Dohle, G. R., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0087-y · Cited by 286
Buvat, J., Maggi, M., Guay, A. T., & Torres, L. O. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02783.x · Cited by 285
Bachman, E., Feng, R., Travison, T., Li, M., Olbina, G., Ostland, V., Ulloor, J., Zhang, A., Basaria, S., Ganz, T., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0864 · Cited by 247
Self-citationAssociation of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial
Roy, C. N., Snyder, P. J., Stephens-Shields, A. J., Artz, A. S., Bhasin, S., Cohen, H. J., Farrar, J. T., Gill, T. M., Zeldow, B., Cella, D., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9540 · Cited by 239
Self-citationThe Hypoxic Testicle: Physiology and Pathophysiology
Reyes, J. G., Farías, J. G., Henríquez-Olavarrieta, S., Eva Madrid, A., Párraga, M., Zepeda, A. B., & Moreno, R. D. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/929285 · Cited by 239
Onset of effects of testosterone treatment and time span until maximum effects are achieved
Saad, F., Aversa, A., Isidori, A. M., Zafalon, L., Zitzmann, M., & Gooren, L. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0221 · Cited by 232
Androgens and erythropoiesis: past and present
Shahani, S., Braga-Basaria, M., Maggio, M., & Basaria, S. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345745 · Cited by 231
Endocrine Aspects of Male Sexual Dysfunctions
Buvat, J., Maggi, M., Gooren, L., Guay, A. T., Kaufman, J., Morgentaler, A., Schulman, C., Tan, H. M., Torres, L. O., Yassin, A., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01780.x · Cited by 221
Late-onset hypogonadism: Current concepts and controversies of pathogenesis, diagnosis and treatment
Huhtaniemi, I. T. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122336 · Cited by 203
Gender-affirming hormones and surgery in transgender children and adolescents
Mahfouda, S., Moore, J. K., Siafarikas, A., Hewitt, T., Ganti, U., Lin, A. P., & Zepf, F. D. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30305-x · Cited by 197
Guo, W., Bachman, E., Li, M., Roy, C. N., Blusztajn, J., Wong, S., Chan, S. Y., Serra, C., Jasuja, R., Travison, T. G., et al. (2013) · Aging Cell · doi:10.1111/acel.12052 · Cited by 192
Anabolic–androgenic steroids: How do they work and what are the risks?
Bond, P., Smit, D. L., & de Ronde, W. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1059473 · Cited by 235
Hilton, E. N., & Lundberg, T. R. (2021) · Sports Medicine · doi:10.1007/s40279-020-01389-3 · Cited by 236
Erythrocytosis Following Testosterone Therapy
Ohlander, S. J., Varghese, B., & Pastuszak, A. W. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.04.001 · Cited by 168
Gianatti, E., Dupuis, P., Hoermann, R., Strauss, B. J., Wentworth, J. M., Zajac, J. D., & Grossmann, M. (2014) · Diabetes Care · doi:10.2337/dc13-2845 · Cited by 168
Harper, J., O'Donnell, E., Sorouri Khorashad, B., McDermott, H., & Witcomb, G. L. (2021) · British Journal of Sports Medicine · doi:10.1136/bjsports-2020-103106 · Cited by 206
Testosterone replacement therapy
Barbonetti, A., D’Andrea, S., & Francavilla, S. (2020) · Andrology · doi:10.1111/andr.12774 · Cited by 175
Testosterone in men with advanced liver disease: Abnormalities and implications
Sinclair, M. J., Grossmann, M., Gow, P. J., & Angus, P. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12695 · Cited by 163
Dean, J. D., McMahon, C. G., Guay, A. T., Morgentaler, A., Althof, S. E., Becher, E. F., Bivalacqua, T. J., Burnett, A. L. “., Buvat, J., Meliegy, A. E., et al. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12952 · Cited by 159
Nieschlag, E., & Vorona, E. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-015-9320-5 · Cited by 176
Risks and benefits of testosterone therapy in older men
Spitzer, M., Huang, G., Basaria, S., Travison, T. G., & Bhasin, S. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.73 · Cited by 154
Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach
Toosy, S., Sodi, R., & Pappachan, J. M. (2018) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0371-5 · Cited by 154
Saad, F., Aversa, A., M. Isidori, A., & J. Gooren, L. (2012) · Current Diabetes Reviews · doi:10.2174/157339912799424573 · Cited by 148
Surampudi, P. N., Wang, C., & Swerdloff, R. S. (2012) · International Journal of Endocrinology · doi:10.1155/2012/625434 · Cited by 154
Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism
Jayasena, C. N., Anderson, R. A., Llahana, S., Barth, J. H., MacKenzie, F., Wilkes, S., Smith, N., Sooriakumaran, P., Minhas, S., Wu, F. C. W., et al. (2022) · Clinical Endocrinology · doi:10.1111/cen.14633 · Cited by 147
Aging and the Male Reproductive System
Kaufman, J., Lapauw, B., Mahmoud, A., T'Sjoen, G. G., & Huhtaniemi, I. T. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00178 · Cited by 150
Sex differences in athletic performance emerge coinciding with the onset of male puberty
Handelsman, D. J. (2017) · Clinical Endocrinology · doi:10.1111/cen.13350 · Cited by 142
Position Stand on Androgen and Human Growth Hormone Use
Hoffman, J. R., Kraemer, W. J., Bhasin, S., Storer, T. W., Ratamess, N. A., Haff, G. G., Willoughby, D. S., & Rogol, A. D. (2009) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e31819df2e6 · Cited by 143
Hormone Replacement Therapy and Physical Function in Healthy Older Men. Time to Talk Hormones?
Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M., & Sonksen, P. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1002 · Cited by 132
Latour, C., Kautz, L., Besson-Fournier, C., Island, M.-L., Canonne-Hergaux, F., Loréal, O., Ganz, T., Coppin, H., & Roth, M.-P. (2014) · Hepatology · doi:10.1002/hep.26648 · Cited by 120
Why Is Androgen Replacement in Males Controversial?
Cunningham, G. R., & Toma, S. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0266 · Cited by 111
Testosterone deficiency in the aging male
McBride, J. A., Carson, C. C., & Coward, R. M. (2015) · Therapeutic Advances in Urology · doi:10.1177/1756287215612961 · Cited by 109
T hrombotic issues in transgender medicine: A review
Shatzel, J. J., Connelly, K. J., & DeLoughery, T. G. (2016) · American Journal of Hematology · doi:10.1002/ajh.24593 · Cited by 101
Borst, S. E., Yarrow, J. F., Conover, C. F., Nseyo, U., Meuleman, J. R., Lipinska, J. A., Braith, R. W., Beck, D. T., Martin, J. S., Morrow, M., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00592.2013 · Cited by 98
Testosterone and glucose metabolism in men: current concepts and controversies
Grossmann, M. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0393 · Cited by 104
Khera, M., Broderick, G. A., Carson, C. C., Dobs, A. S., Faraday, M. M., Goldstein, I., Hakim, L. S., Hellstrom, W. J. G., Kacker, R., Köhler, T. S., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.022 · Cited by 99
Characteristics and Attitudes of Men Using Anabolic Androgenic Steroids (AAS): A Survey of 2385 Men
Bonnecaze, A. K., O’Connor, T., & Aloi, J. (2020) · American Journal of Men s Health · doi:10.1177/1557988320966536 · Cited by 96
Maggio, M., Snyder, P. J., Ceda, G. P., Milaneschi, Y., Luci, M., Cattabiani, C., Masoni, S., Vignali, A., Volpi, R., Lauretani, F., et al. (2012) · Andrology · doi:10.1111/j.2047-2927.2012.00009.x · Cited by 91
Madsen, M. C., van Dijk, D., Wiepjes, C. M., Conemans, E. B., Thijs, A., & den Heijer, M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab089 · Cited by 91
Adverse effects of testosterone replacement therapy: an update on the evidence and controversy
Grech, A., Breck, J., & Heidelbaugh, J. (2014) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614548680 · Cited by 81
Androgens and prostate cancer; pathogenesis and deprivation therapy
Grossmann, M., Cheung, A. S., & Zajac, J. D. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.05.001 · Cited by 91
A randomized trial of adjunct testosterone for cancer‐related muscle loss in men and women
Wright, T. J., Dillon, E. L., Durham, W. J., Chamberlain, A., Randolph, K. M., Danesi, C. P., Horstman, A. M. H., Gilkison, C. R., Willis, M., Richardson, G., et al. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12295 · Cited by 89
Idan, A., Griffiths, K. A., Harwood, D. T., Seibel, M. J., Turner, L., Conway, A. J., & Handelsman, D. J. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-10-201011160-00004 · Cited by 89
Male late-onset hypogonadism: pathogenesis, diagnosis and treatment
Huhtaniemi, I., & Forti, G. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.47 · Cited by 88
Diagnosis and treatment of hypogonadism in men
Bhasin, S., & Basaria, S. S. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.12.002 · Cited by 89
The vulnerable man: impact of testosterone deficiency on the uraemic phenotype
Carrero, J. J., & Stenvinkel, P. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs383 · Cited by 90
Androgens and the Regulation of Adiposity and Body Fat Distribution in Humans
Tchernof, A., Brochu, D., Maltais‐Payette, I., Mansour, M. F., Marchand, G. B., Carreau, A., & Kapeluto, J. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170009 · Cited by 113
Bhasin, S., Lincoff, A. M., Basaria, S. S., Bauer, D. C., Boden, W. E., Cunningham, G. R., Davey, D. A., Dubcenco, E., Fukumoto, S., Garcia, M., et al. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.11.016 · Cited by 88
Testosterone and the aging male: To treat or not to treat?
Bain, J. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.01.009 · Cited by 84
Regulators of hepcidin expression
Roth, M., Meynard, D., & Coppin, H. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.005 · Cited by 86
Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male
Jones, S. D., Dukovac, T., Sangkum, P., Yafi, F. A., & Hellstrom, W. J. G. (2015) · Sexual Medicine Reviews · doi:10.1002/smrj.43 · Cited by 76
The practical management of testosterone deficiency in men
Aversa, A., & Morgentaler, A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.238 · Cited by 75
Jacobeit, J. W., Gooren, L. J., & Schulte, H. M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0412 · Cited by 73
Vita, R., Settineri, S., Liotta, M., Benvenga, S., & Trimarchi, F. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.10.012 · Cited by 73
Bonnecaze, A. K., O’Connor, T., & Burns, C. A. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-021-06751-3 · Cited by 84
Cardiovascular Disease in Anabolic Androgenic Steroid Users
Windfeld‐Mathiasen, J., Heerfordt, I. M., Dalhoff, K., Andersen, J. T., Andersen, M. A., Johansson, K. S., Biering‐Sørensen, T., Olsen, F. J., & Horwitz, H. (2025) · Circulation · doi:10.1161/circulationaha.124.071117 · Cited by 69
Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism
Pencina, K. M., Travison, T. G., Artz, A. S., Lincoff, A. M., Nissen, S. E., Flevaris, P., Chan, A., Li, X., Diegel, S. A., Wannemuehler, K. A., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.40030 · Cited by 69
Association Between Testosterone Replacement Therapy and the Incidence of DVT and Pulmonary Embolism
Sharma, R., Oni, O. A., Chen, G., Sharma, M., Dawn, B., Sharma, R., Parashara, D., Savin, V. J., Barua, R. S., & Gupta, K. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.05.007 · Cited by 68
Yarrow, J. F., McCoy, S. C., & Borst, S. E. (2010) · Steroids · doi:10.1016/j.steroids.2010.01.019 · Cited by 69
Hematological changes during androgen deprivation therapy
Grossmann, M., & Zajac, J. D. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2011.102 · Cited by 62
Fabbro, E. D., Garcia, J. M., Dev, R., Hui, D., Williams, J. L., Engineer, D., Palmer, J. L., Schover, L. R., & Bruera, E. D. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-1832-5 · Cited by 64
Magnussen, L. V., Glintborg, D., Hermann, A. P., HOUGAARD, D. M., Højlund, K., & Andersen, M. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12701 · Cited by 64
Chiang, J. M., Kaysen, G. A., Segal, M. R., Chertow, G. M., Delgado, C., & Johansen, K. L. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy252 · Cited by 62
Ip, F. F., di Pierro, I., Brown, R., Cunningham, I., Handelsman, D. J., & Liu, P. Y. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0717 · Cited by 59
Male hypogonadism: pathogenesis, diagnosis, and management
de Silva, N. L., Papanikolaou, N., Grossmann, M., Antonio, L., Quinton, R., Anawalt, B. D., & Jayasena, C. N. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00199-2 · Cited by 68
Effects of anabolic-androgens on brain reward function
Mhillaj, E., Morgese, M. G., Tucci, P., Bové, M., Schiavone, S., & Trabace, L. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00295 · Cited by 57
Beggs, L. A., Yarrow, J. F., Conover, C. F., Meuleman, J. R., Beck, D. T., Morrow, M., Zou, B., Shuster, J. J., & Borst, S. E. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00184.2014 · Cited by 59
O’Shaughnessy, P. J., Monteiro, A., Bhattacharya, S., Fraser, M., & Fowler, P. (2012) · Molecular Human Reproduction · doi:10.1093/molehr/gas059 · Cited by 58
Anabolic-Androgenic Steroid Use in Sports, Health, and Society
Bhasin, S., Hatfield, D. L., Hoffman, J. R., Kraemer, W. J., LaBotz, M., Phillips, S. M., & Ratamess, N. A. (2021) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002670 · Cited by 63
Aging and androgens: Physiology and clinical implications
Anawalt, B. D., & Matsumoto, A. M. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09765-2 · Cited by 55
Androgen Physiology, Pharmacology, and Abuse
Handelsman, D. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00138-4 · Cited by 54
Gonzales, G. F., Gasco, M., Tapia, V., & Gonzales-Castañeda, C. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90940.2008 · Cited by 51
Bassil, N. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.03.001 · Cited by 50
Rochira, V., Zirilli, L., Madeo, B., MAFFEI, L. E., & Carani, C. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.12.007 · Cited by 50
Dhindsa, S., Ghanim, H., Batra, M., Kuhadiya, N. D., Abuaysheh, S., Green, K., Makdissi, A., Chaudhuri, A., & Dandona, P. (2016) · Clinical Endocrinology · doi:10.1111/cen.13130 · Cited by 49
Kuikman, M. A., Mountjoy, M., & Burr, J. F. (2021) · Nutrients · doi:10.3390/nu13082601 · Cited by 50
Haematological actions of androgens
Warren, A. M., & Grossmann, M. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101653 · Cited by 59
Testosterone Therapy in Adolescent Boys: The Need for a Structured Approach
Stancampiano, M. R., Lucas-Herald, A. K., Russo, G., Rogol, A. D., & Ahmed, S. F. (2019) · Hormone Research in Paediatrics · doi:10.1159/000504670 · Cited by 49
Wheeler, K. M., Smith, R. P., Kumar, R. A., Setia, S., Costabile, R. A., & Kavoussi, P. K. (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.068 · Cited by 47
Testosterone Deficiency as One of the Major Endocrine Disorders in Chronic Kidney Disease
Romejko, K., Rymarz, A., Sadownik, H., & Niemczyk, S. (2022) · Nutrients · doi:10.3390/nu14163438 · Cited by 52
Sex Differences in Iron Status and Hepcidin Expression in Rats
Kong, W.-N., Niu, Q.-M., Ge, L., Zhang, N., Yan, S., Chen, W., Chang, Y., & Zhao, S.-E. (2014) · Biological Trace Element Research · doi:10.1007/s12011-014-0051-3 · Cited by 50
An update on male hypogonadism therapy
Surampudi, P. N., Swerdloff, R. S., & Wang, C. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.913022 · Cited by 46
Maggio, M. G., Vita, F. D., Fisichella, A., Lauretani, F., Ticinesi, A., Ceresini, G., Cappola, A. R., Ferrucci, L., & Ceda, G. P. (2015) · International Journal of Endocrinology · doi:10.1155/2015/292574 · Cited by 44
Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency
Traish, A. M. (2017) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.10.001 · Cited by 46
Retinoic acid receptor antagonists for male contraception: current status†
Noman, M. A. A., Kyzer, J. L., Chung, S. S. W., Wolgemuth, D. J., & Georg, G. I. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa122 · Cited by 45
Complications of injectable testosterone undecanoate in routine clinical practice
Middleton, T. L., Turner, L., Fennell, C., Savkovic, S., Jayadev, V., Conway, A. J., & Handelsman, D. J. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0891 · Cited by 44
Yeap, B. B., Page, S. T., & Grossmann, M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30416-3 · Cited by 43
Reference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP project
Bjerner, J., Biernat, D., Fosså, S. D., & Bjøro, T. (2009) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365510903380886 · Cited by 41
Hematologic Markers and Prostate Cancer Risk: A Prospective Analysis in UK Biobank
Watts, E. L., Perez‐Cornago, A., Kothari, J., Allen, N. E., Travis, R. C., & Key, T. J. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1525 · Cited by 41
Metadata
- Authors
- Coviello, A. D., Kaplan, B., Lakshman, K. M., Chen, T., Singh, A. B., & Bhasin, S.
- Affiliations
- Boston University (US)
- Charles R. Drew University of Medicine and Science (US)
- Corresponding author
- Coviello, Andrea D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-03-01
- Volume
- 93
- Issue
- 3
- Pages
- 914-919
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2266950
- OpenAlex
- W2102205904
- Cited by
- 404
- References
- 38
- Citations by year
- 2026: 12 · 2025: 27 · 2024: 25 · 2023: 34 · 2022: 34 · 2021: 21 · 2020: 30 · 2019: 18 · 2018: 18 · 2017: 24 · 2016: 20 · 2015: 23 · 2014: 19 · 2013: 23 · 2012: 24
- FWCI
- 8.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- School of Medicine, Boston University
- National Institutes of Health
- National Institute on Aging (1R01 AG-14369-01, R01AG014369)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK049296, 2R01 DK49296-08, R01DK070534, R01DK059627)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD0434)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- testosterone replacement therapy, erythropoiesis, erythrocytosis, testosterone enanthate, dose-response relationship, hemoglobin, hematocrit, erythropoietin, soluble transferrin receptor, age differences, older men, GnRH agonist
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Dose-Response Relationship, Drug, Erythropoiesis, Erythropoietin, Hematocrit, Hemoglobins, Humans, Male, Middle Aged, Receptors, Transferrin, Testosterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review